Poland· PL-100487781
Abrysvo
A respiratorisches-synzytial-virus impfstoffe product containing szczepionka przeciw syncytialnemu wirusowi oddechowemu (rsv) (biwalentna, rekombinowana), registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka przeciw syncytialnemu wirusowi oddechowemu (RSV) (biwalentna, rekombinowana)
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Poland (PL)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- gtin054150621162101 fiol. proszku + amp.-strzyk. z rozpuszczalnikiem + adapter fiolki + igłaPLN 817.72
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Respiratorisches-synzytial-virus impfstoffe in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMRESVIAMODERNA BIOTECH SPAIN, S.L., Madrid
- United KingdomAbrysvo vaccine powder and solvent for solution for injection 0.5ml vialsPfizer Ltd
- NetherlandsmRESVIA dispersie voor injectie in een voorgevulde spuit mRNA-vaccin tegen het respiratoir syncytieel virusModerna Biotech Spain S.L.
- United StatesRespiratory Syncytial Virus NosodeProfessional Complementary Health Formulas
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6d8a7fea-e083-4adf-ad4e-671ca8b0743e GET /v1/drugs/6d8a7fea-e083-4adf-ad4e-671ca8b0743e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "-",
"packaging": "05415062116210 ¦ Rp ¦ EU/1/23/1752/001 ¦ 151291\n1 igła + 1 adapter fiolki ¦ 1 fiol. z proszkiem ¦ 1 amp.-strzyk. z rozp.\nRp ¦ EU/1/23/1752/003 ¦ 151292\n5 amp.-strzyk. z rozp. ¦ 5 fiol. z proszkiem ¦ 5 igła + 5 adapterów fiolki\nRp ¦ EU/1/23/1752/005 ¦ 151293\n10 igła + 10 adapterów fiolki ¦ 10 amp.-strzyk. z rozp. ¦ 10 fiol. z proszkiem\nRp ¦ EU/1/23/1752/002 ¦ 151528\n1 fiol. z proszkiem ¦ 1 amp.-strzyk. z rozp. + 1 adapter fiolki\nRp ¦ EU/1/23/1752/006 ¦ 151529\n10 fiol. z proszkiem ¦ 10 amp.-strzyk. z rozp. + 10 adapterów fiolki\nRp ¦ EU/1/23/1752/004 ¦ 151530\n5 amp.-strzyk. z rozp. + 5 adapterów fiolki ¦ 5 fiol. z proszkiem\nRp ¦ EU/1/23/1752/007 ¦ 162292\n5 fiol. z proszkiem ¦ 5 fiol. z rozp. (opakowanie 5-cio dawkowe)\nRp ¦ EU/1/23/1752/008 ¦ 162293\n10 fiol. z proszkiem ¦ 10 fiol. z rozp. (opakowanie 10-cio dawkowe)",
"substance": null,
"common_name": "Szczepionka przeciw syncytialnemu wirusowi oddechowemu (RSV) (biwalentna, rekombinowana)",
"pl_product_id": "100487781",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.